Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 6/2009

01-12-2009 | Original Paper

Drug Use, High-Risk Sex Behaviors, and Increased Risk for Recent HIV Infection among Men who Have Sex with Men in Chicago and Los Angeles

Authors: James W. Carey, Roberto Mejia, Trista Bingham, Carol Ciesielski, Deborah Gelaude, Jeffrey H. Herbst, Michele Sinunu, Ekow Sey, Nikhil Prachand, Richard A. Jenkins, Ron Stall

Published in: AIDS and Behavior | Issue 6/2009

Login to get access

Abstract

We examined how drugs, high-risk sexual behaviors, and socio-demographic variables are associated with recent HIV infection among men who have sex with men (MSM) in a case–control study. Interviewers collected risk factor data among 111 cases with recent HIV infection, and 333 HIV-negative controls from Chicago and Los Angeles. Compared with controls, cases had more unprotected anal intercourse (UAI) with both HIV-positive and HIV-negative partners. MSM with lower income or prior sexually transmitted infections (STI) were more likely to be recently HIV infected. Substances associated with UAI included amyl nitrate (“poppers”), methamphetamine, Viagra® (or similar PDE-5 inhibitors), ketamine, and gamma hydroxybutyrate (GHB). Cases more frequently used Viagra®, poppers, and methamphetamine during UAI compared with controls. In multivariate analysis, income, UAI with HIV-positive partners, Viagra®, and poppers remained associated with recent HIV seroconversion. Better methods are needed to prevent HIV among MSM who engage in high-risk sex with concurrent drug use.
Literature
Boerma, J. T., & Weir, S. S. (2005). Integrating demographic and epidemiological approaches to research HIV/AIDS: The proximate determinants framework. Journal of Infectious Diseases, 191, S61–S67.CrossRefPubMed
Buchacz, K., McFarland, W., Kellogg, T. A., Loeb, L., Holmberg, S. D., Dilley, J., et al. (2005). Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS, 19, 1423–1424.CrossRefPubMed
Buchbinder, S. P., Vittinghoff, E., Heagerty, P. J., Celum, C. L., Seage, G., Judson, F. N., et al. (2005). Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. Journal of Acquire Immune Deficiency Syndromes, 39, 82–89.CrossRef
Catania, J. A., Osmond, D., Stall, R. D., Pollack, L., Paul, J. P., Blower, S., et al. (2001). The continuing HIV epidemic among men who have sex with men. American Journal of Public Health, 91, 907–914.CrossRefPubMed
CDC. (2005). HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men—five U.S. cities, June 2004-April. Morbidity and Mortality Weekly Report, 54, 597–601.
CDC. (2007). HIV/AIDS Surveillance Report, 2005. Vol. 17. Rev. Ed. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention.
Celentano, D. D., Valleroy, L. A., Sifakis, F., MacKellar, D. A., Hylton, J., Thiede, H., et al. (2006). Associations between substance use and sexual risk among very young men who have sex with men. Sexually Transmitted Diseases, 33, 265–271.PubMed
Chesney, M. A., Barrett, D. C., & Stall, R. (1998). Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. American Journal of Public Health, 88, 113–116.CrossRefPubMed
Chou, R., Huffman, L. H., Fu, R., Smits, A. K., & Korthuis, P. T. (2005). Screening for HIV: A review of the evidence for the U.S. Preventive Task Force. Annals of Internal Medicine, 143, 55–73.PubMed
Chu, P. L., McFarland, W., Gibson, S., Weide, D., Henne, J., Miller, P., et al. (2003). Viagra use in a community-recruited sample of men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndromes, 33, 191–193.CrossRefPubMed
Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., et al. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health, 82(Suppl.1), i62–i70.PubMed
Drumright, L. N., Little, S. J., Strathdee, S. A., Slymen, D. J., Araneta, M. R. G., Malcarne, V. L., et al. (2006a). Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. Journal of Acquired Immune Deficiency Syndromes, 43, 344–350.CrossRefPubMed
Drumright, L. N., Patterson, T. L., & Strathdee, S. A. (2006b). Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Substance Use and Misuse, 41, 1551–1601.CrossRefPubMed
Fenton, K. A., & Valdiserri, R. O. (2006). Twenty-five years of HIV/AIDS—United States, 1981–2006. Morbidity and Mortality Weekly Report, 55, 585–589.
Giancola, P. R., & Tarter, R. (1999). Executive cognitive functioning and risk for substance abuse. Psychology Science, 10, 203–207.CrossRef
Gibson, D. R., Flynn, N. M., & McCarthy, J. J. (1999). Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 13, 1807–1818.CrossRefPubMed
Greenwald, J. L., Rich, C. A., Bessega, S., Posner, M., Maeda, J. L., & Skolnik, P. R. (2006). Evaluation of the Centers for Disease Control and Prevention’s recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing? Mayo Clinic Procedures, 81, 452–458.CrossRef
Halkitis, P. N., Green, K. A., & Mourgues, P. (2005). Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from Project BUMPS. Journal of Urban Health, 82(Suppl. 1), i18–i25.PubMed
Herbst, J. H., Sherba, R. T., Crepaz, N., Deluca, J. B., Zohrabyan, L., Stall, R. D., et al. (2005). A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. Journal of AIDS, 39, 228–241.PubMed
Hirshfield, S., Remien, R. H., Humberstone, M., Walavalkar, I., & Chiasson, M. A. (2004). Substance use and high-risk sex among men who have sex with men: A national online study in the USA. AIDS Care, 16, 1036–1047.CrossRefPubMed
Janssen, R. S., Satten, G. A., Stramer, S. L., Rawal, B. D., O’Brien, T. R., Weiblen, B. J., et al. (1998). New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Journal of the American Medical Association, 280, 42–48.CrossRefPubMed
Kim, A. A., Kent, C. K., & Klausner, J. D. (2002). Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000–2001. Journal of Acquired Immunodeficiency Syndromes, 16, 1425–1428.
Kleinbaum, D. G. (2002). Epidemiologic methods: the “art” in the state of the art. Journal of Clinical Epidemiology, 55, 1196–1200.CrossRefPubMed
Koblin, B. A., Husnik, M. J., Colfax, G., Huang, Y., Madison, M., Mayer, K., et al. (2006). Risk factors for HIV infection among men who have sex with men. Journal of Acquired Immunodeficiency Syndromes, 20, 731–739.
Kothe, D., Byers, R. H., Caudill, S. P., Satten, G. A., Janssen, R. S., Hannon, W. H., et al. (2003). Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. Journal of Acquired Immune Deficiency Syndromes, 33, 625–634.CrossRefPubMed
Leigh, B. C., & Stall, R. (1993). Substance use and risky sexual behavior for exposure to HIV: Issues in methodology, interpretation, and prevention. American Psychologist, 48, 1035–1045.CrossRefPubMed
Loeb, L. (2004). Viagra: the science and politics of drugs, sex, and risk. Focus, 19, 4–7.PubMed
MacDonald, N., Elam, G., Hickson, F., Imrie, J., McGarrigle, C. A., Fenton, K. A., et al. (2008). Factors associated with HIV seroconversion in gay men in England at the start of the 21st century. Sexually Transmitted Infections, 84, 8–13.CrossRefPubMed
Mansergh, G., Shouse, R. L., Marks, G., Guzman, R., Rader, M., Buchbinder, S., et al. (2006). Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sexually Transmitted Infections, 82, 131–134.CrossRefPubMed
Marks, G., Crepaz, N., Senterfitt, J. W., & Janssen, R. S. (2005). Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes, 39, 446–453.CrossRefPubMed
Mausbach, B. T., Semple, S. J., Strathdee, S. A., Zians, J., & Patterson, T. L. (2007). Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: Results from the EDGE study. Drug and Alcohol Dependence, 87, 249–257.CrossRefPubMed
McKirnan, D. G., Ostrow, B. H., & Hope, B. (1996). Sex, drugs and escape: A psychological model of HIV-risk sexual behaviours. AIDS Care, 8, 655–669.CrossRefPubMed
McNal, M., & Remafedi, G. (1999). Relationship of amphetamine and other substance use to unprotected intercourse among young men who have sex with men. Archives of Pediatric and Adolescence Medicine, 153, 1130–1135.
Metzger, D. S., & Navaline, H. (2003). Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases, 37(Suppl. 5), S451–S456.CrossRefPubMed
Metzger, D. S., Navaline, H., & Woody, G. E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl. 1), 97–106.PubMed
Metzger, D. S., Woody, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H., et al. (1993). Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6, 1049–1056.PubMed
Molitor, F., Truax, S. R., Ruiz, J. D., & Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine, 168, 93–97.PubMed
Mustanski, B. (2008). Moderating effects of age on the alcohol and sexual risk taking association: An online daily diary study of men who have sex with men. AIDS and Behavior, 12, 118–126.CrossRefPubMed
Nagelkerke, N. J. D. (1991). A note on a general definition of the coefficient of determination. Biometrika, 78, 691–692.CrossRef
Newman, P. A., Rhodes, F., & Weiss, R. E. (2004). Correlates of sex trading among drug-using men who have sex with men. American Journal of Public Health, 94, 1998–2003.CrossRefPubMed
Ostrow, D. G., Beltran, E. D., Joseph, J. G., DiFranceisco, W., Wesch, J., & Chmiel, J. S. (1993). Recreational drugs and sexual behavior in the Chicago MACS/CCS cohort of homosexually active men. Journal of Substance Abuse, 5, 311–325.CrossRefPubMed
Patterson, T. L., Semple, S. J., Zians, J. K., & Strathdee, S. A. (2005). Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. Journal of Urban Health, 82(Suppl. 1), i120–i126.PubMed
Paul, J. P., Pollack, L., Osmond, D., & Catania, J. A. (2005). Viagra (sildenafil) use in a population-based sample of U.S. men who have sex with men. Sexually Transmitted Diseases, 32, 531–533.CrossRefPubMed
Plankey, M. W., Ostrow, D. G., Stall, R., Cox, C., Li, X., Peck, J. A., et al. (2007). The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndromes, 45, 85–92.CrossRefPubMed
Purcell, D. W., Moss, S., Remien, R. H., Woods, W. J., & Parsons, J. T. (2005a). Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners. Journal of Acquired Immunodeficiency Syndromes, 19(Suppl. 1), S37–S47.
Purcell, D. W., Parsons, J. T., Halkitis, P. N., Mizuno, Y., & Woods, W. J. (2001). Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. Journal of Substance Abuse, 13, 185–200.CrossRefPubMed
Purcell, D. W., Wolitski, R. J., Hoff, C. C., Parsons, J. T., Woods, W. J., & Halkitis, P. N. (2005b). Predictors of the use of viagra, testosterone, and antidepressants among HIV-seropositive gay and bisexual men. Journal of Acquired Immunodeficiency Syndromes, 19, S57–S66.
Rawal, B. D., Regula, A., Lebedeva, L., Janssen, R. S., Hecht, F. M., Sheppard, H. W., et al. (2003). Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 33, 349–355.PubMed
Romanelli, F., & Smith, K. M. (2004). Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males. Annals of Pharmacotherapy, 38, 1024–1030.CrossRefPubMed
Rosen, R. C., Catania, J. A., Ehrhardt, A. A., Burnett, A., Lue, T., McKenna, K., et al. (2006). The Bolger Conference on PDE-5 Inhibition and HIV risk: implications for health policy and prevention. Journal of Sexual Medicine, 3, 960–975.CrossRefPubMed
Sanchez, T., Finlayson, T., Drake, A., Behel, S., Cribbin, M., DiNenno, E., et al. (2006). Human immunodeficiency virus (HIV) risk, prevention, testing behaviors—United States, National HIV Behavioral Surveillance System: Men who have sex with men, November 2003–April 2005. Morbidity and Mortality Weekly Reports: Surveillance Summaries, 55(SS6), 1–16.
Sanchez, T. H., & Gallagher, K. M. (2006). Factors associated with recent sildenafil (Viagra) use among men who have sex with men in the United States. Journal of Acquired Immunodeficiency Syndromes, 42, 95–100.CrossRef
Schlesselman, J. J. (1982). Case–control studies: Design, conduct, analysis. New York: Oxford University Press.
Shoptaw, S., & Reback, C. J. (2007). Methamphetamine use and infectious disease-related behaviors in men who have sex with men: Implications for interventions. Addiction, 102(Suppl. 1), 130–135.CrossRefPubMed
Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., et al. (2005). Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78, 125–134.CrossRefPubMed
Stall, R., Mills, T. C., Williamson, J., Hart, T., Greenwood, G., Paul, J., et al. (2003). Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. American Journal of Public Health, 93, 939–942.CrossRefPubMed
Stall, R., Paul, J. P., Greenwood, G., Pollack, L. M., Bein, E., Crosby, G. M., et al. (2001). Alcohol use, drug use and alcohol-related problems among men who have sex with men: The Urban Men’s Health Study. Addiction, 96, 1589–1601.CrossRefPubMed
Stall, R., & Purcell, D. W. (2000). Intertwining epidemics: A review in research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS and Behavior, 4, 181–192.CrossRef
Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(Suppl.3), iii7–iii14.PubMed
Swearingen, S. G., & Klausner, J. D. (2005). Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. American Journal of Medicine, 118, 571–577.CrossRefPubMed
Thiede, H., Jenkins, R. A, Carey, J. W., Hutcheson, R., Thomas, K. K., Stall, R., White, E., Allen, I., Mejia, R., and Golden, M. (2008). Determinants of recent HIV infection among Seattle-area men who have sex with men. American Journal Public Health (in press).
Thiede, H., Valleroy, L. A., MacKellar, D. A., Celentano, D. D., Ford, W. L., Hagan, H., et al. (2003). Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. American Journal of Public Health, 93, 1915–1921.CrossRefPubMed
Wolitski, R. J., Henny, K. D., Lyles, C. M., Purcell, D. W., Carey, J. W., Crepaz, N., et al. (2006). Evolution of HIV/AIDS prevention programs—United States, 1981–2006. Morbidity and Mortality Weekly Reports, 55, 597–603.
Metadata
Title
Drug Use, High-Risk Sex Behaviors, and Increased Risk for Recent HIV Infection among Men who Have Sex with Men in Chicago and Los Angeles
Authors
James W. Carey
Roberto Mejia
Trista Bingham
Carol Ciesielski
Deborah Gelaude
Jeffrey H. Herbst
Michele Sinunu
Ekow Sey
Nikhil Prachand
Richard A. Jenkins
Ron Stall
Publication date
01-12-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9403-3

Other articles of this Issue 6/2009

AIDS and Behavior 6/2009 Go to the issue

Original Paper

Community, Family, and Partner-Related Stigma Experienced by Pregnant and Postpartum Women with HIV in Ho Chi Minh City, Vietnam

Original Paper

Lessons Learned about Behavioral Science and Acute/Early HIV Infection. The NIMH Multisite Acute HIV Infection Study: V

Original Paper

Lack of Understanding of Acute HIV Infection among Newly-Infected Persons—Implications for Prevention and Public Health: The NIMH Multisite Acute HIV Infection Study: II

Original Paper

Differential Disclosure Across Social Network Ties Among Women Living with HIV

Review Paper

From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures

Original Paper

Unsafe Sexual Behaviors among HIV-positive Men in Kathmandu Valley, Nepal
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits